Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study

被引:0
作者
Janine M. Simons
Julien G. Jacobs
Joost P. Roijers
Maarten A. Beek
Leandra J. M. Boonman-de Winter
Arjen M. Rijken
Paul D. Gobardhan
Jan H. Wijsman
Eric Tetteroo
Joan B. Heijns
C. Y. Yick
Ernest J. T. Luiten
机构
[1] Amphia Hospital,Department of Surgical Oncology
[2] Amphia Hospital,Research Department
[3] Amphia Hospital,Department of Radiology
[4] Amphia Hospital,Department of Medical Oncology
[5] Amphia Hospital,Department of Pathology
来源
Breast Cancer Research and Treatment | 2021年 / 185卷
关键词
Breast cancer; Lumpectomy; Mastectomy; Survival; Neoadjuvant chemotherapy; Breast-conserving surgery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:441 / 451
页数:10
相关论文
共 348 条
[31]  
Wolmark N(2019)Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database Breast Cancer Res Treat 173 301-567
[32]  
Veronesi U(2018)Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy Breast Cancer Res Treat 170 559-3354
[33]  
Cascinelli N(2012)Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy Eur J Cancer 48 3342-172
[34]  
Mariani L(2014)Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis Lancet 384 164-1804
[35]  
Greco M(2012)Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes J Clin Oncol 30 1796-516
[36]  
Saccozzi R(2016)Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy JAMA Oncol 2 508-951
[37]  
Luini A(2018)A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy Ann Surg 267 946-undefined
[38]  
Aguilar M(undefined)undefined undefined undefined undefined-undefined
[39]  
Marubini E(undefined)undefined undefined undefined undefined-undefined
[40]  
Jatoi I(undefined)undefined undefined undefined undefined-undefined